Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Many people prescribed GLP-1s for weight loss report GI side effects and a drastically reduced appetite, which can make it incredibly difficult to eat enough to meet basic needs let alone thrive
The drug was designed for once-weekly subcutaneous administration and early clinical investigation of tirzepatide demonstrated exceptional efficacy for glucose lowering and weight loss in T2DM
A compounded product is considered essentially a copy if it has the same API as a commercially available drug in the same, similar, or easily substitutable strength, and can be used by the same route of administration, unless the prescriber documents a patient-specific change that produces a significant difference
GLP-1RA therapy inhibits glucagon secretion, at least transiently delays gastric emptying, and reduces appetite and food intake [60,61]
US$ 26.65
US$ 20.74
US$ 20.80
US$ 27.07
